ConductScience.org, home

Paper698125

Acceleration of methaemoglobin reduction by riboflavin in human erythrocytes.

Matsuki T and 7 others. Br J Haematol, 1978. Cited by 26 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Acceleration of methaemoglobin reduction by riboflavin in human erythrocytes. Papers, record 698125. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/698125

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Acceleration of methaemoglobin reduction by riboflavin in human erythrocytes.
PubMed
Journal
Br J Haematol
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
26
iCite
Relative citation ratio, by iCite
1.21
iCite
Revised in PubMed
2019-07-04
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Matsuki TT
2Yubisui TT
3Tomoda AA
4Yoneyama YY
5Takeshita MM
6Hirano MM
7Kobayashi KK
8Tani YY

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ErythrocytesMajor topic
MethemoglobinMajor topic
RiboflavinMajor topic
Cytochrome-B(5) Reductase
Deoxyglucose
Enzyme Activation
Glucose
Humans
In Vitro Techniques
Methemoglobinemia
Stimulation, Chemical

Source PubMed

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.

PMIDTitleJournalYearIn PapersSource
31,861,871Vitreous Antioxidants, Degeneration, and Vitreo-Retinopathy: Exploring the Links.Antioxidants (Basel)2019https://conductscience.org/library/papers/31861871PubMed
23,913,015PharmGKB summary: methylene blue pathway.Pharmacogenet Genomics2013https://conductscience.org/library/papers/23913015PubMed
10,602,728In vitro activity of riboflavin against the human malaria parasite Plasmodium falciparum.Antimicrob Agents Chemother2000https://conductscience.org/library/papers/10602728PubMed
7,305,986Age-dependent decay of cytochrome b5 and cytochrome b5 reductase in human erythrocytes.Biochem J1981https://conductscience.org/library/papers/7305986PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
DECR11,666PubTator's text mininghttps://conductscience.org/library/genes/1666

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/698125

GET https://conductscience.org/api/papers/v1/698125/authors